Waters Corporation (WAT)
Quantitative Summary
DeterministicWAT trades at 48.8x earnings, roughly in line with its sector average of 65.2x. Financial health is average: Piotroski 4/9, Altman Z 11.7. DCF fair value of $49 implies 85% downside based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Waters Corporation reflect a high-quality earnings engine driven primarily by superior profitability rather than operational leverage or balance sheet expansion. The company generates an ROIC-WACC spread of 5.0%, indicating value creation that outpaces the cost of capital, while DuPont analysis reveals this return stems from robust net margins at 20.3% and moderate asset turnover of 0.62x supported by a leverage multiplier near 2.0x. Qualitative risk metrics present a mixed picture; although the Altman Z-Score of 11.1 and negative Beneish M-Score of -2.38 suggest low distress probability and minimal earnings manipulation, the Piotroski F-Score of 4/9 signals moderate financial stability relative to peers. Despite these structural strengths, recent performance has underperformed broad factor models, evidenced by an annualized Fama-French Alpha of -37.37% and a neutral stance on value factors (HML), even as the Profitability Factor remains robust at 0.221.
Valuation metrics indicate significant divergence between current market pricing and intrinsic model estimates. Trading at a forward P/E of 28.2x, the stock is notably undervalued relative to its sector average of 36.8x, yet this discount aligns with a DCF-derived fair value that implies an -83.7% downside from current levels based on projected free cash flow growth assumptions. This steep valuation gap suggests the market may be pricing in aggressive long-term headwinds despite management's implied ability to sustain high FCF expansion rates over ten years at 32.6%. The disconnect between strong historical profitability and a deeply discounted multiple highlights potential concerns regarding future visibility or execution risk that are not captured by static margin analysis alone.
Recent insider activity provides a counter-narrative to the bearish valuation thesis, with $451,070 in net buying over the last 90 days suggesting management confidence despite the wide DCF gap. However, investors must weigh this internal support against the persistent underperformance relative to factor-based benchmarks and the substantial implied discount required by the DCF model. The synthesis of strong fundamental generation metrics with a deeply depressed valuation creates an asymmetric setup where realized returns depend heavily on whether future growth assumptions converge closer to current market expectations or if the stock re-rates based on improved operational momentum.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 7% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 10% | 12% | 14% |
|---|---|---|---|
| 2% | $57 | $45 | $37 |
| 3% | $64 | $49 | $39 |
| 4% | $73 | $53 | $42 |
Center = base case. Green = >10% upside, Red = >10% downside vs $371.93.
Pre-computed DCF: WACC=12.0%, terminal growth 3%. Fair value $49 (-85.0%). Not investment advice.
Valuation Context
Currently trading 65% below its 5-year average P/E of 83.9x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedWaterstone Medical Retail Group Inc. (WAT) is trading below both its 50-day and 200-day simple moving averages, suggesting it may be in a short-term downtrend relative to recent price action. The Relative Strength Index (RSI) reading of 28.1 indicates that the stock is currently in oversold territory, which could signal potential near-term buying pressure or stabilization based on historical patterns.
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like VOT or XLV, the fund manager is mechanically forced to buy or sell WAT shares regardless of Waters Corporation's individual fundamentals. We estimate $4.2B of passive capital is structurally linked to WAT through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Waters Corporation to visualize passive redemption contagion across ETFs and collateral stocks.
If Waters Corporation (WAT) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ELI LILLY + CO (LLY) as the most exposed collateral stock, sharing 1 ETFs with WAT. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 30 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
WAT Ownership Dynamics
Passive funds hold 1 in every 7 WAT shares, reducing daily market volatility.
Waters Corporation (WAT) exerts measurable gravity on the passive index market, currently representing 0.7% of the VOT (VOT) and 0.6% of the State Street Health Care Select Sector SPDR ETF (XLV). Across 30 tracked ETFs, approximately 14M shares (14.4% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest WAT Exposure
Float lock-up computed from 30 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
WAT Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Waters Corporation over the past year sits near $299.39 (13% of 252-day volume). The current price of $371.93 trades 24.2% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (13% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
WAT Capital Efficiency
How efficiently does Waters Corporation convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Waters Corporation converts 52% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The positive ROIC-WACC spread of 5.0% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 488 | $334.93 | $163,445.84 |
| 2026-05-13 | 24,817 | $352.21 | $8.7M |
| 2026-05-12 | 253 | $348.07 | $88,061.71 |
| 2026-05-06 | 4,879 | $342.75 | $1.7M |
| 2026-05-05 | 2,241 | $301.88 | $676,513.08 |
| 2026-05-04 | 474 | $307.12 | $145,574.88 |
| 2026-04-29 | 478 | $300.73 | $143,748.94 |
| 2026-04-27 | 56 | $309.87 | $17,352.72 |
| 2026-04-24 | 462 | $311.20 | $143,774.4 |
| 2026-04-23 | 2,397 | $334.38 | $801,508.86 |
| 2026-04-22 | 658 | $335.23 | $220,581.34 |
| 2026-04-21 | 1,000 | $335.61 | $335,610 |
| 2026-04-20 | 881 | $327.77 | $288,765.37 |
| 2026-04-17 | 9,933 | $319.04 | $3.2M |
| 2026-04-16 | 962 | $326.20 | $313,804.4 |
| 2026-04-13 | 743 | $320.00 | $237,760 |
| 2026-04-10 | 380 | $317.65 | $120,707 |
| 2026-04-08 | 1,802 | $307.38 | $553,898.76 |
| 2026-04-02 | 38 | $299.89 | $11,395.82 |
| 2026-03-27 | 4,648 | $300.56 | $1.4M |
| 2026-03-25 | 11 | $301.92 | $3,321.12 |
| 2026-03-23 | 564 | $298.99 | $168,630.36 |
| 2026-03-20 | 141 | $299.57 | $42,239.37 |
| 2026-03-19 | 374 | $295.05 | $110,348.7 |
| 2026-03-18 | 123 | $296.99 | $36,529.77 |
| 2026-03-17 | 271 | $290.02 | $78,595.42 |
| 2026-03-13 | 42,770 | $283.32 | $12.1M |
| 2026-03-09 | 14,857 | $302.54 | $4.5M |
| 2026-03-06 | 7,075 | $315.59 | $2.2M |
| 2026-03-05 | 252 | $319.04 | $80,398.08 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| A | 0.731 | 0.599 | High co-movement |
| MTD | 0.678 | 0.516 | Moderate |
| DHR | 0.669 | 0.489 | Moderate |
| TMO | 0.641 | 0.507 | Moderate |
| GEHC | 0.516 | 0.458 | Moderate |
| MRK | 0.501 | 0.425 | Moderate |
| NDSN | 0.495 | 0.393 | Moderate |
| IQV | 0.494 | 0.312 | Moderate |
| SWK | 0.484 | 0.350 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare WAT to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.